Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ocrelizumab in adults with primary progressive multiple sclerosis has posted results assessing efficacy and safety; the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Multiple Sclerosis, Primary Progressive | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-02-23